When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
Saved in:
| Main Authors: | Moritake Iguchi, Hiromichi Wada, Felipe Martínez, Koji Hasegawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-06-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2022.62 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?
by: Maki Komiyama, et al.
Published: (2024-07-01) -
When should children with HIV infection be started on antiretroviral therapy?
by: Steven B Welch, et al.
Published: (2008-03-01) -
Benign Infantile Hydrocephalus: In Which Child, When Should We Think, What Should We Do?
by: Cem Cahit Barışık, et al.
Published: (2022-05-01) -
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice
by: Giuseppe Rosano, et al.
Published: (2020-11-01) -
When Should We Stop Breeding Dairy Cows?
by: Klibs N. Galvão, et al.
Published: (2014-09-01)